Logo-apb
Adv Pharm Bull. 2022;12(2): 206-216. doi: 10.34172/apb.2022.023
PMID: 35620342        PMCID: PMC9106958

Editorial

Mesenchymal Stem Cells in the Treatment of New Coronavirus Pandemic: A Novel Promising Therapeutic Approach

Sara Razi 1,2 ORCID, Zahra Molavi 1, Seyed Amir Mirmotalebisohi 3,4, Zahra Niknam 1, Marzieh Sameni 3,4, Vahid Niazi 5, Amirjafar Adibi 6, Mohsen Yazdani 7, Mohammad Mehdi Ranjbar 8, Hakimeh Zali 1,5 * ORCID

Cited by CrossRef: 2


1- Nemati M, Jafari A, Ebrahimi Y, Golchin A, Pouya F, Rezaei‐Tavirani M, Rasmi Y. Laboratory methods: A concise review and update for COVID‐19 diagnosis. Cell Biochemistry & Function. 2023;41(4):413 [Crossref]
2- Kim S, Kim O, Hong H, Ju J, Lee D. Etanercept-synthesizing adipose-derived stem cell secretome: A promising therapeutic option for inflammatory bowel disease. World J Gastrointest Surg. 2024;16(3):882 [Crossref]
3- Niknam Z, Jafari A, Golchin A, Danesh Pouya F, Nemati M, Rezaei-Tavirani M, Rasmi Y. Potential therapeutic options for COVID-19: an update on current evidence. Eur J Med Res. 2022;27(1) [Crossref]